Lung Cancer

Molecular and Genetic Aspects of Lung Cancer.- Detection of Altered Tumor Markers in Clinical Samples for Diagnosis and Prognosis.- Molecular Alterations in Lung Cancer.- Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas.- Clinical Implications of p53 Mutations in Lung Cancer.- An Epidemiologic and Clinicopathologic Overview of AIDS-Associated Pulmonary Kaposi’s Sarcoma.- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk.- Clinical Utility of Tumor Markers in the Management of Non-Small Cell Lung Cancer.- Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH).- In Situ Analysis of Telomerase RNA Gene Expression as a Marker for Tumor Progression.- A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers.- Expression Profiling of Lung Cancer Based on Suppression Subtraction Hybridization (SSH).- Comparative Genomic Hybridization of Human Lung Cancer.- Sensitive Assays for Detection of Lung Cancer.- Fluorescent Microsatellite Analysis in Bronchial Lavage as a Potential Diagnostic Tool for Lung Cancer.- Southern Blotting of Genomic DNA from Lung and Its Tumors.- Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk.- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer.- Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT.- Detection of K-ras and p53 Mutations by “Mutant-Enriched” PCR-RFLP.- Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor.- Utilization of ThyroidTranscription Factor-1 Immunostaining in the Diagnosis of Lung Tumors.- Molecular Biologic Substaging of Stage I NSCLC Through Immunohistochemistry Performed on Formalin-Fixed, Paraffin-Embedded Tissue.- A Sensitive Immunofluorescence Assay for Detection of p53 Protein in the Sputum.- SPR1.- Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer.- Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System.- Reconstruction of Geno-Phenotypic Evolutionary Sequences from Intracellular Patterns of Molecular Abnormalities in Human Solid Tumors.- Novel Therapies.- Surgical Treatment of Lung Cancer.- Recent Advances and Dilemmas in the Radiotherapeutic Management of Locally Advanced Non-Small Cell Lung Cancer.- Photodynamic Therapy in Lung Cancer.- Gene Therapy for Lung Cancer.- Identifying Obstacles to Viral Gene Therapy for Lung Cancer.- Topical Gene Therapy for Pulmonary Diseases with PEI-DNA Aerosol Complexes.- Targeted Delivery of Expression Plasmids to the Lung via Macroaggregated Polyethylenimine-Albumin Conjugates.- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer.- Aerosol Gene Therapy for Metastatic Lung Cancer Using PEI-p53 Complexes.- Clinical Development of Antisense Oligonucleotides as Anti-Cancer Therapeutics.- Antisense Oligonucleotides Targeting RI? Subunit of Protein Kinase A.- Use of Antisense Oligonucleotides for Therapy.- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide.- Tumor Vaccination with Cytokine-Encapsulated Microspheres.- Adoptive Immunotherapy.- Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models.- Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in LungCancer.- Chemoprevention of Lung Cancer.- Assessing the Interaction of Particulate Delivery Systems with Lung Surfactant.- Chemopreventive Therapeutics.